Sebastien K.
- Country
- Belgium
- Department
- UZ Brussel
Research Overview
- Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study of Brenipatide (LY3537031) for Efficacy and Safety in Adults with Irritable Bowel Syndrome‑Constipation
- Efficacy of Citalopram in Patients with Reflux Hypersensitivity or Functional Heartburn Unresponsive to Proton Pump Inhibitors: A Placebo-Controlled Study
- Efficacy of Prucalopride in Patients with Gastro-Esophageal Reflux Disease and Incomplete Proton Pump Inhibitor Response: A Placebo-Controlled Study
Data & Insights
Has run more than one trial at 9 of 72 partner sites.
Specializations
Gastrointestinal Motility Disorders
This investigator specializes in treating conditions affecting digestive system movement, particularly focusing on gastroparesis and its various manifestations in both idiopathic and diabetic patients.
- Idiopathic Gastroparesis
- Diabetic Gastroparesis
- Delayed Gastric Emptying
The research explores innovative therapeutic approaches for patients with compromised stomach motility function.
Reflux Disease Management
The investigator conducts research in gastro-esophageal reflux disease (GERD), with particular attention to cases that show resistance to conventional treatments.
- Refractory GERD
- Reflux Hypersensitivity
- Functional Heartburn
Treatment investigations focus on patients who demonstrate incomplete response to standard PPI therapy.
Therapeutic Innovations
The investigator explores novel therapeutic agents for gastrointestinal disorders, including prokinetics and other medication classes for digestive system disorders.
- Advanced GERD Therapeutics
- Motility-Enhancing Treatments
- Alternative Treatment Approaches
Research focuses on developing treatment options for patients with complex gastrointestinal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.